Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The combination enables investigation of VEGFR2-mediated growth factor signalling alongside actin cytoskeleton dynamics, offering researchers comprehensive tools for studying complex cellular processes
No serious adverse events have been documented in research settings no organ toxicity, no hormonal disruption, no cardiac complications, and no major drug interactions
There is no FDA-approved human trial yet
When the number of platelets is low, one may complain of prolonged bleeding from cuts, bleeding gums or nose, blood in urine or stool, abnormally heavy menstrual periods in women, fatigue and general weakness
Compounded GHK-Cu is not an FDA-approved drug product
What if I cannot tolerate the combination at all
US$ 23.88
US$ 24.35
US$ 24.59
US$ 25.13
US$ 28.57
